U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230444) titled 'Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization' on Nov. 13.
Brief Summary: Uterine artery embolization is a minimally invasive treatment for symptomatic uterine fibroids, but intra-procedural assessment of embolization adequacy currently relies on subjective angiographic criteria. This study evaluates a proprietary angiographic analysis software (AQ-VERO) that extracts quantitative time-to-density perfusion metrics in real time. The study aims to (1) validate the accuracy and reproducibility of AQ-VERO during uterine artery mebolization, and (2) develop an AI-based decision support system ...